Diagnostic approach in cases with suspected work-related asthma

Journal of Occupational Medicine and Toxicology

Volumn 8, Issue 1, 2013, Pages

  Aasen, Tor B ^a   Burge, P Sherwood ^b   Henneberger, Paul K ^c   Schlünssen, Vivi ^d   Baur, Xaver ^e  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Asthma; Diagnosis; Occupational disease; Work related

Indexed keywords

ALLERGEN;

FOLLOW UP; FORCED EXPIRATORY VOLUME; GOLD STANDARD; HUMAN; INHALATION TEST; LUNG FUNCTION; MEASUREMENT; OCCUPATIONAL ASTHMA; PEAK EXPIRATORY FLOW; REVIEW; SKIN TEST; SPIROMETRY; STANDARDIZATION; SYSTEMATIC REVIEW (TOPIC); WORKPLACE;

EID: 84878894294     PISSN: None     EISSN: 17456673     Source Type: Journal    
DOI: 10.1186/1745-6673-8-17     Document Type: Review

References (123)

1. Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, Asthma in the workplace and related conditions New York: Taylor & Francis 3 2006
2. Surveillance of occupational asthma under the SENSOR model. Matte TD, Hoffman RE, Rosenman KD, Stanbury M, Chest 1990 98 173S 178S 2226005 (Pubitemid 20369979)
3. Primary prevention: exposure reduction, skin exposure and respiratory protection. Heederik D, Henneberger PK, Redlich CA, Eur Respir Rev 2012 21 112 124 10.1183/09059180.00005111 22654083
4. What are the benefits of medical screening and surveillance? Wilken D, Baur X, Barbinova L, Preisser A, Meijer E, Rooyackers J, et al. Eur Respir Rev 2012 21 105 111 10.1183/09059180.00005011 22654082
5. Beach J, Rowe BH, Blitz S, Crumley E, Hooton N, Russel K, et al. Diagnosis and Management of Work-Related Asthma Rockville, MD: Agency for Healthcare Research and Quality 2005
6. Nicholson PJ, Cullinan P, Burge PS, Boyle C, Occupational asthma: Prevention, identification & management: Systematic review & recommendations London: British Occupational Health Research Foundation 2010 23806457
7. Diagnosis and Management of Work-Related Asthma: American College of Chest Physicians Consensus Statement. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Chest 2008 134 1S 41S 10.1378/chest.08-0201 18779187
8. The management of work-related asthma guidelines: a broader perspective. Baur X, Aasen TB, Burge PS, Heederik D, Henneberger PK, Maestrelli P, et al. Eur Respir Rev 2012 21 125 139 10.1183/09059180.00004711 22654084
9. The new guidelines for management of work-related asthma. Baur X, Sigsgaard T, Eur Respir J 2012 39 518 519 10.1183/09031936.00096211 22379145
10. Guidelines for the management of work-related asthma. Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, et al. Eur Respir J 2012 39 529 545 10.1183/09031936.00096111 22379148
11. What is the optimal management option for occupational asthma? Vandenplas O, Dressel H, Nowak D, Jamart J, Eur Respir Rev 2012 21 97 104 10.1183/09059180.00004911 22654081
12. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chan-Yeung M, Chest 1995 108 1084 1117 10.1378/chest.108.4.1084 7555124
13. Occupational asthma. Chan-Yeung M, Malo JL, N Engl J Med 1995 333 107 112 10.1056/NEJM199507133330207 7777015
14. Global Strategy for Asthma Management and Prevention 2010 Available from http://www.ginasthma.org
15. National asthma education and prevention program-Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-Summary report 2007. [Anon], J Allergy Clin Immunol 2007 120 94 S138 17983880
16. The definition and diagnosis of asthma. Hargreave FE, Nair P, Clin Exp Allergy 2009 39 1652 1658 10.1111/j.1365-2222.2009.03321.x 19622089
17. A comparison of the validity of different diagnostic tests in adults with asthma. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID, Chest 2002 121 1051 1057 10.1378/chest.121.4.1051 11948032 (Pubitemid 34280422)
18. The overlap syndrome of asthma and COPD: what are its features and how important is it? Gibson PG, Simpson JL, Thorax 2009 64 728 735 10.1136/thx.2008.108027 19638566
19. Overdiagnosis of asthma in the community. LindenSmith J, Morrison D, Deveau C, Hernandez P, Can Respir J 2004 11 111 116 15045041 (Pubitemid 38519169)
20. Occupational asthma in the developing and industrialised world: a review. Jeebhay MF, Quirce S, Int J Tuberc Lung Dis 2007 11 122 133 17263280 (Pubitemid 46219273)
21. Sox HC, Blatt M, Higgins M, Marton KI, Medical Decision Making Stoneham, MA: Butterworths 1988
22. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. J Allergy Clin Immunol 2004 113 832 836 10.1016/j.jaci.2003.12.591 15131563 (Pubitemid 38608590)
23. Bronchial asthma and COPD due to irritants in the workplace-an evidence-based approach. Baur X, Bakehe P, Vellguth H, J Occup Med Toxicol 2012 7 19 10.1186/1745-6673-7-19 23013890
24. Allergens causing occupational asthma: an evidence-based evaluation of the literature. Baur X, Bakehe P, Int Arch Occup Environ Health 2013 Apr 18. [Epub ahead of print]
25. Airborne allergens and irritants in the workplace. Baur X, In Allergy and allergic diseases Oxford: Blackwell Publishing, Kay AB, Kaplan AP, Bousquet J, Holt PG, 2008 1017 1022
26. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. Malo JL, Ghezzo H, d'Aquino C, L'Archeveque J, Cartier A, Chan-Yeung M, J Allergy Clin Immunol 1992 90 937 944 10.1016/0091-6749(92)90466-F 1460199 (Pubitemid 23004590)
27. The value of questionnaires and spirometry in asthma surveillance programmes in the workplace. Stenton SC, Beach JR, Avery AJ, Hendrick DJ, Occup Med (Lond) 1993 43 203 206 10.1093/occmed/43.4.203 (Pubitemid 23313089)
28. Occupational asthma in symptomatic workers exposed to natural rubber latex: evaluation of diagnostic procedures. Vandenplas O, Binard-Van CF, Brumagne A, Caroyer JM, Thimpont J, Sohy C, et al. J Allergy Clin Immunol 2001 107 542 547 10.1067/mai.2001.113519 11240958 (Pubitemid 32210038)
29. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Baur X, Huber H, Degens PO, Allmers H, Ammon J, Am J Ind Med 1998 33 114 122 10.1002/(SICI)1097-0274(199802)33:2<114::AID-AJIM3>3.0.CO;2-Y 9438044 (Pubitemid 28028148)
30. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Cote J, Kennedy S, Chan-Yeung M, Thorax 1993 48 48 51 10.1136/thx.48.1.48 8434353 (Pubitemid 23032780)
31. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. Cote J, Kennedy S, Chan-Yeung M, J Allergy Clin Immunol 1990 85 592 598 10.1016/0091-6749(90)90098-O 2179365 (Pubitemid 20099002)
32. Is the clinical history a satisfactory means of diagnosing occupational asthma? Malo JL, Ghezzo H, L'Archeveque J, Lagier F, Perrin B, Cartier A, Am Rev Respir Dis 1991 143 528 532 10.1164/ajrccm/143.3.528 2001062
33. Asthma due to the complex salts of platinum-a cross-sectional survey of workers in a platinum refinery. Merget R, Schultze-Werninghaus G, Muthorst T, Friedrich W, Meier-Sydow J, Clin Allergy 1988 18 569 580 10.1111/j.1365-2222. 1988.tb02908.x 2468431 (Pubitemid 19000205)
34. Prevalence of occupational asthma due to latex among hospital personne. Vandenplas O, Delwiche JP, Evrard G, Aimont P, VandB X, Jamart J, et al. Am J Respir Crit Care Med 1995 151 54 60 10.1164/ajrccm.151.1.7812572 7812572
35. A comparison of some of the characteristics of patients with occupational and non-occupational asthma. Axon EJ, Beach JR, Burge PS, Occup Med (Lond) 1995 45 109 111 10.1093/occmed/45.2.109
36. Inhalation challenge with bovine dander allergens: who needs it? Koskela H, Taivainen A, Tukiainen H, Chan HK, Chest 2003 124 383 391 10.1378/chest.124.1.383 12853550 (Pubitemid 36851379)
37. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Malo JL, Lemiere C, Desjardins A, Cartier A, Eur Respir J 1997 10 1513 1515 10.1183/09031936.97.10071513 9230239 (Pubitemid 27311064)
38. Occupational asthma due to exposure to iroko wood dust. Ricciardi L, Fedele R, Saitta S, Tigano V, Mazzeo L, Fogliani O, et al. Ann Allergy Asthma Immunol 2003 91 393 397 10.1016/S1081-1206(10)61687-0 14582819 (Pubitemid 37266344)
39. Guidelines for assessing and managing asthma risk at work, school, and recreation. American Thoracic Society, Am J Respir Crit Care Med 2004 169 873 881 15044221
40. Standardization of spirometry - 1987 update. Official statement of American Thoracic Society. American Thoracic Society, Respir Care 1987 32 1039 1060 10315742
41. Standardisation of spirometry. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Eur Respir J 2005 26 319 338 10.1183/09031936.05.00034805 16055882 (Pubitemid 41079078)
42. Peak flow rate records in the diagnosis of occupational asthma due to colophony. Burge PS, O'Brien IM, Harries MG, Thorax 1979 34 308 316 10.1136/thx.34.3.308 483205 (Pubitemid 9223973)
43. Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma. Park D, Moore VC, Burge CB, Jaakkola MS, Robertson AS, Burge PS, Eur Respir J 2009 34 574 578 10.1183/09031936.00150108 19324953
44. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Am J Respir Crit Care Med 2000 161 309 329 10619836
45. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Eur Respir J Suppl 1993 16 53 83 8499055
46. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS, Thorax 2002 57 231 236 10.1136/thorax.57.3.231 11867827 (Pubitemid 34214409)
47. Sensitisation to occupational allergens in bakers' asthma and rhinitis: a case-referent study. Brisman J, Lillienberg L, Belin L, Ahman M, Jarvholm B, Int Arch Occup Environ Health 2003 76 167 170 12733091 (Pubitemid 36740735)
48. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Burge PS, Thorax 1982 37 348 353 10.1136/thx.37.5.348 7112471 (Pubitemid 12125191)
49. Specific serum antibodies against isocyanates: association with occupational asthma. Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, et al. J Allergy Clin Immunol 1989 84 507 514 10.1016/0091-6749(89)90364-3 2794294 (Pubitemid 19266747)
50. Occupational asthma without bronchial hyperresponsiveness. Hargreave FE, Ramsdale EH, Pugsley SO, Am Rev Respir Dis 1984 130 513 515 6089628 (Pubitemid 14029789)
51. Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity. Lemiere C, Cartier A, Malo JL, Lehrer SB, Am J Respir Crit Care Med 2000 162 976 980 10.1164/ajrccm.162.3. 9910031 10988116
52. New method for an occupational dust challenge test. Lin FJ, Chen H, Chan-Yeung M, Occup Environ Med 1995 52 54 56 10.1136/oem.52.1.54 7697142
53. Quantitative skin prick and bronchial provocation tests with platinum saltMerget. Merget R, Schultze-Werninghaus G, Bode F, Bergmann EM, Zachgo W, Meier-Sydow J, Br J Ind Med 1991 48 830 837 1772797
54. Absence of relationship between degree of nonspecific and specific bronchial responsiveness in occupational asthma due to platinum salts. Merget R, Dierkes A, Rueckmann A, Bergmann EM, Schultze-Werninghaus G, Eur Respir J 1996 9 211 216 10.1183/09031936.96.09020211 8777953 (Pubitemid 26068613)
55. Toluene diisocyanate-induced asthma: clinical findings and bronchial responsiveness studies in 113 exposed subjects with work-related respiratory symptoms. Moscato G, Dellabianca A, Vinci G, Candura SM, Bossi MC, J Occup Med 1991 33 720 725 10.1097/00043764-199106000-00014 1650820
56. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Perrin B, Lagier F, L'Archeveque J, Cartier A, Boulet LP, Cote J, et al. Eur Respir J 1992 5 40 48 1577147
57. Outcome of assessments for occupational asthma. Tarlo SM, Broder I, Chest 1991 100 329 335 10.1378/chest.100.2.329 1864102
58. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of the European Academy of Allergology and Clinical Immunology. American Academy of Allergy and Clinical Immunology. European Respiratory Society. American College of Allergy, Asthma and Immunology. Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R, Eur Respir J 1995 8 1605 1610 8575590
59. Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2. Baldwin DR, Gannon P, Bright P, Newton DT, Robertson A, Venables K, et al. Thorax 2002 57 860 864 10.1136/thorax.57.10. 860 12324671 (Pubitemid 35178609)
60. Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Anees W, Gannon PF, Huggins V, Pantin CF, Burge PS, Eur Respir J 2004 23 730 734 10.1183/09031936.04.00027304 15176688 (Pubitemid 38618144)
61. Improving the quality of peak flow measurements for the diagnosis of occupational asthma. Huggins V, Anees W, Pantin C, Burge S, Occup Med (Lond) 2005 55 385 388 10.1093/occmed/kqi072 (Pubitemid 41158562)
62. PEF analysis requiring shorter records for occupational asthma diagnosis. Moore VC, Jaakkola MS, Burge CB, Pantin CF, Robertson AS, Vellore AD, et al. Occup Med (Lond) 2009 59 413 17 10.1093/occmed/kqp081
63. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Leroyer C, Perfetti L, Trudeau C, L'Archeveque J, Chan-Yeung M, Malo JL, Am J Respir Crit Care Med 1998 158 827 832 10.1164/ajrccm.158.3.9707093 9731012 (Pubitemid 28449448)
64. Peak expiratory flow rates in possible occupational asthma. Liss GM, Tarlo SM, Chest 1991 100 63 69 10.1378/chest.100.1.63 2060392
65. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Malo JL, Cote J, Cartier A, Boulet LP, L'Archeveque J, Chan-Yeung M, Thorax 1993 48 1211 1217 10.1136/thx.48.12.1211 8303625 (Pubitemid 24009386)
66. OASYS-3: improved analysis of serial peak expiratory flow in suspected occupational asthma. Bright P, Newton DT, Gannon PF, Pantin CF, Burge PS, Monaldi Arch Chest Dis 2001 56 281 288 11665511 (Pubitemid 32951972)
67. A new diagnostic score for occupational asthma: the area between the curves (ABC score) of peak expiratory flow on days at and away from work. Moore VC, Jaakkola MS, Burge CB, Robertson AS, Pantin CF, Vellore AD, et al. Chest 2009 135 307 314002E 10.1378/chest.08-0778 18812450
68. A Systematic Review of Serial Peak Expiratory Flow Measurements in the Diagnosis of Occupational Asthma. Moore VC, Jaakkola MC, Burge PS, Annals of Respiratory Medicine 2009 1 31 44
69. Allergen standardization and skin tests. Dreborg S, Frew A, Allergy 1993 48 49 54 8457026
70. Developments in laboratory diagnostics for isocyanate asthma. Wisnewski AV, Curr Opin Allergy Clin Immunol 2007 7 138 145 10.1097/ACI.0b013e3280895d22 17351466 (Pubitemid 46411513)
71. A systematic review of the diagnosis of occupational asthma. Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C, et al. Chest 2007 131 569 578 10.1378/chest.06-0492 17296663 (Pubitemid 46280421)
72. Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma? Budnik LT, Preisser AM, Permentier H, Baur X, Int Arch Occup Environ Health 2012 86 417 430 22544379
73. Asthma and rhinitis related to laboratory rats: use of a purified rat urinary allergen to study exposure in laboratories and the human immune response. Platts-Mills TA, Longbottom J, Edwards J, Heymann PW, N Engl Reg Allergy Proc 1987 8 245 251 10.2500/108854187779032451 3478580
74. Diagnostic validation of specific IgE antibody concentrations, skin prick testing, and challenge tests in chemical workers with symptoms of sensitivity to different anhydrides. Baur X, Czuppon A, J Allergy Clin Immunol 1995 96 489 494 10.1016/S0091-6749(95)70292-X 7560660
75. Utility of antibody in identifying individuals who have or will develop anhydride-induced respiratory disease. Grammer L, Shaughnessy M, Kenamore B, Chest 1998 114 1199 1202 10.1378/chest.114.4.1199 9792595 (Pubitemid 28495920)
76. Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody. Howe W, Venables KM, Topping MD, Dally MB, Hawkins R, Law JS, et al. J Allergy Clin Immunol 1983 71 5 11 10.1016/0091-6749(83)90539-0 6822691 (Pubitemid 13183896)
77. Occupational asthma and IgE antibodies to reactive dyes. Park HS, Kim YJ, Lee MK, Hong CS, Yonsei Med J 1989 30 298 304 2588667 (Pubitemid 20080567)
78. Role of skin prick test and serological measurement of specific IgE in the diagnosis of occupational asthma resulting from exposure to vinyl sulphone reactive dyes. Park JW, Kim CW, Kim KS, Choi SY, Kang DB, Ko SH, et al. Occup Environ Med 2001 58 411 416 10.1136/oem.58.6.411 11351058 (Pubitemid 32488097)
79. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, et al. Am J Respir Crit Care Med 2002 166 445 450 10.1164/rccm.2109018 12186818
80. L'épreuve de provocation bronchiqueest-ellejustifiée en patologierespiratoireprofessionnelle? Pauli G, Soldatov D, Kopferschmitt-Kubler MC, Rev Pneumol Clin 1996 52 97 102 8761639
81. Inhalation challenges with agents causing occupational asthma. Vandenplas O, Malo JL, Eur Respir J 1997 10 2612 2629 10.1183/09031936.97.10112612 9426105 (Pubitemid 28048642)
82. Use of specific inhalation challenge in the evaluation of workers at risk for occupational asthma: a survey of pulmonary, allergy, and occupational medicine residency training programs in the United States and Canada. Ortega HG, Weissman DN, Carter DL, Banks D, Chest 2002 121 1323 1328 10.1378/chest.121.4. 1323 11948069 (Pubitemid 34280459)
83. Workplace specific challenges as a contribution to the diagnosis of occupational asthma. Rioux JP, Malo JL, L'Archeveque J, Rabhi K, Labrecque M, Eur Respir J 2008 2008 2008
84. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Pepys J, Hutchcroft BJ, Am Rev Respir Dis 1975 112 829 859 173214
85. Respiratory disease in workers exposed to solder flux fumes containing colophony (pine resin). Burge PS, Harries MG, O'Brien IM, Pepys J, Clin Allergy 1978 8 1 14 10.1111/j.1365-2222.1978.tb00441.x 414855 (Pubitemid 8275124)
86. Statistical approaches to the identification of late asthmatic reactions. Stenton SC, Avery AJ, Walters EH, Hendrick DJ, Eur Respir J 1994 7 806 812 10.1183/09031936.94.07040806 8005264 (Pubitemid 24122979)
87. Diagnosis of occupational asthma from time point differences in serial PEF measurements. Burge CB, Moore VC, Pantin CF, Robertson AS, Burge PS, Thorax 2009 64 1032 1036 10.1136/thx.2009.120923 19850961
88. Changes in sputum cell counts after exposure to occupational agents: what do they mean? Lemiere C, Chaboillez S, Malo JL, Cartier A, J Allergy Clin Immunol 2001 107 1063 1068 10.1067/mai.2001.115486 11398086 (Pubitemid 32523349)
89. Standardized methodology of sputum induction and processing. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE, Eur Respir J 2002 20 Suppl 37 1 55 12166553
90. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Maestrelli P, Saetta M, Di SA, Calcagni PG, Turato G, Ruggieri MP, et al. Am J Respir Crit Care Med 1995 152 1926 1931 10.1164/ajrccm.152.6.8520757 8520757
91. Noninvasive assessment of airway inflammation in asthma. Kips JC, Kharitonov SA, Barnes PJ, Eur Respir Mon 2003 23 164 179
92. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, et al. J Allergy Clin Immunol 2005 115 720 727 10.1016/j.jaci.2004.12.1129 15805990 (Pubitemid 40460845)
93. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Lancet 2002 360 1715 1721 10.1016/S0140-6736(02)11679-5 12480423 (Pubitemid 35447900)
94. Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma. Di Franco A, Vagaggini B, Bacci E, Bartoli ML, Cianchetti S, Carnevali S, et al. Respir Med 1998 92 550 557 10.1016/S0954-6111(98)90307-9 9692121 (Pubitemid 28162170)
95. Diagnosing occupational asthma: use of induced sputum. Lemiere C, Pizzichini MM, Balkissoon R, Clelland L, Efthimiadis A, O'Shaughnessy D, et al. Eur Respir J 1999 13 482 488 10.1183/09031936.99.13348299 10232413 (Pubitemid 29180152)
96. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Maestrelli P, Calcagni PG, Saetta M, Di SA, Hosselet JJ, Santonastaso A, et al. Clin Exp Allergy 1994 24 29 34 10.1111/j.1365-2222.1994. tb00913.x 8156442 (Pubitemid 24210812)
97. The use of sputum eosinophils in the evaluation of occupational asthma. Lemiere C, Curr Opin Allergy Clin Immunol 2004 4 81 85 10.1097/00130832- 200404000-00002 15021058 (Pubitemid 38581534)
98. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Obata H, Dittrick M, Chan H, Chan-Yeung M, Eur Respir J 1999 13 489 495 10.1183/09031936.99.13348999 10232414 (Pubitemid 29180153)
99. Eosinophilic bronchitis in the workplace. Quirce S, Curr Opin Allergy Clin Immunol 2004 4 87 91 10.1097/00130832-200404000-00003 15021059 (Pubitemid 38581535)
100. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. ATS/ERS, Am J Respir Crit Care Med 2005 171 912 930 15817806
101. Increased amount of nitric oxide in exhaled air of asthmatics. Alving K, Weitzberg E, Lundberg JM, Eur Respir J 1993 6 1368 1370 7507065 (Pubitemid 23329557)
102. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Baur X, Barbinova L, Eur Respir J 2005 25 309 316 10.1183/09031936.05.00021504 15684296 (Pubitemid 40246532)
103. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ, Am J Respir Crit Care Med 1995 151 1894 1899 10.1164/ajrccm.151.6.7767537 7767537
104. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE, J Allergy Clin Immunol 2000 106 638 644 10.1067/mai.2000.109622 11031333
105. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Am J Respir Crit Care Med 2004 169 473 478 10.1164/rccm.200310-1376OC 14644933 (Pubitemid 38187119)
106. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR, N Engl J Med 2005 352 2163 2173 10.1056/NEJMoa043596 15914548 (Pubitemid 40727083)
107. Exhaled and nasal nitric oxide is increased in laboratory animal allergy. Adisesh LA, Kharitonov SA, Yates DH, Snashell DC, Newman-Taylor AJ, Barnes PJ, Clin Exp Allergy 1998 28 876 880 10.1046/j.1365-2222.1998.00332.x 9720822 (Pubitemid 28335566)
108. Challenge from methacholine, natural rubber latex, or 4,4-diphenylmethane diisocyanate in workers with suspected sensitization affects exhaled nitric oxide [change in exhaled NO levels after allergen challenges]. Allmers H, Chen Z, Barbinova L, Marczynski B, Kirschmann V, Baur X, Int Arch Occup Environ Health 2000 73 181 186 10.1007/s004200050025 10787133 (Pubitemid 30192659)
109. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Barbinova L, Baur X, Int Arch Occup Environ Health 2006 79 387 395 10.1007/s00420-005-0051-x 16421715
110. Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers? Lund MB, Oksne PI, Hamre R, Kongerud J, Occup Environ Med 2000 57 274 278 10.1136/oem.57.4.274 10810115 (Pubitemid 30265436)
111. Exhaled nitric oxide among pulpmill workers reporting gassing incidents involving ozone and chlorine dioxide. Olin AC, Ljungkvist G, Bake B, Hagberg S, Henriksson L, Toren K, Eur Respir J 1999 14 828 831 10.1034/j.1399-3003.1999. 14d18.x 10573229 (Pubitemid 29519345)
112. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Piipari R, Piirila P, Keskinen H, Tuppurainen M, Sovijarvi A, Nordman H, Eur Respir J 2002 20 1532 1537 10.1183/09031936.02.00041802 12503715 (Pubitemid 35460624)
113. Exhaled breath condensate: methodological recommendations and unresolved questions. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, et al. Eur Respir J 2005 26 523 548 10.1183/09031936.05.00029705 16135737 (Pubitemid 41264218)
114. Exhaled Nitric Oxide and Breath Condensate pH in Asthmatic Reactions Induced by Isocyanates. Ferrazzoni S, Scarpa MC, Guarnieri G, Corradi M, Mutti A, Maestrelli P, Chest 2009 136 155 162 10.1378/chest.08-2338 19225065
115. Comparison of peak expiratory flow variability between workers with work-exacerbated asthma and occupational asthma. Chiry S, Cartier A, Malo JL, Tarlo SM, Lemiere C, Chest 2007 132 483 488 10.1378/chest.07-0460 17505025 (Pubitemid 47282380)
116. Workplace respiratory irritants and asthma. Tarlo SM, Occup Med 2000 15 471 484 10769351
117. Reactive airways dysfunction syndrome (RADS). Brooks SM, Weiss MA, Bernstein IL, Persistent asthma syndrome after high level irritant exposures. Chest 1985 88 376 384
118. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Brooks SM, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K, Chest 1998 113 42 49 10.1378/chest.113.1.42 9440566 (Pubitemid 28044922)
119. Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable. Burge PS, Moore VC, Robertson AS, Occup Med (Lond) 2012 62 129 133 10.1093/occmed/kqr211
120. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Piirila PL, Nordman H, Keskinen HM, Luukkonen R, Salo SP, Tuomi TO, et al. Am J Respir Crit Care Med 2000 162 516 522 10.1164/ajrccm.162.2.9909026 10934080 (Pubitemid 30647193)
121. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, et al. J Allergy Clin Immunol 1993 91 850 861 10.1016/0091-6749(93)90342-D 8473673 (Pubitemid 23118501)
122. Air analysis and biomarkers of isocyanates. Skarping G, Dalene M, Karlsson D, Marand A, Dahlin J, Adamsson M, et al. ZentralblArbeitsmedArbeitsschutzProphylErgonomie 2005 55 6 14 (Pubitemid 40254487)
123. Hnizdo E, Yu L, Freyder L, Attfield M, Lefante J, Glindmeyer HW, Occup Environ Med 2005 62 695 701 10.1136/oem.2004.018424 16169915 (Pubitemid 41360895)